| Product Code: ETC13279138 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Hemophilia B Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Hemophilia B Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Hemophilia B Market Revenues & Volume, 2021 & 2031F |
3.3 North America Hemophilia B Market - Industry Life Cycle |
3.4 North America Hemophilia B Market - Porter's Five Forces |
3.5 North America Hemophilia B Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Hemophilia B Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 North America Hemophilia B Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 North America Hemophilia B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 North America Hemophilia B Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 North America Hemophilia B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Hemophilia B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Hemophilia B Market Trends |
6 North America Hemophilia B Market, 2021 - 2031 |
6.1 North America Hemophilia B Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Hemophilia B Market, Revenues & Volume, By Plasma Derived Coagulation Factor Concentrate, 2021 - 2031 |
6.1.3 North America Hemophilia B Market, Revenues & Volume, By Recombinant Coagulation Factor Concentrates, 2021 - 2031 |
6.1.4 North America Hemophilia B Market, Revenues & Volume, By Desmopressin, 2021 - 2031 |
6.1.5 North America Hemophilia B Market, Revenues & Volume, By Others, 2020 - 2028 |
6.2 North America Hemophilia B Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Hemophilia B Market, Revenues & Volume, By On-Demand, 2021 - 2031 |
6.2.3 North America Hemophilia B Market, Revenues & Volume, By Prophylaxis, 2021 - 2031 |
6.3 North America Hemophilia B Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Hemophilia B Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 North America Hemophilia B Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.4 North America Hemophilia B Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.2 North America Hemophilia B Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Hemophilia B Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 North America Hemophilia B Market, Revenues & Volume, By Specialty Clinics, 2020 - 2028 |
6.4.5 North America Hemophilia B Market, Revenues & Volume, By Others, 2020 - 2028 |
6.5 North America Hemophilia B Market, Revenues & Volume, By Distribution Channel, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America Hemophilia B Market, Revenues & Volume, By Hospital Pharmacy, 2020 - 2028 |
6.5.3 North America Hemophilia B Market, Revenues & Volume, By Online Pharmacy, 2020 - 2028 |
6.5.4 North America Hemophilia B Market, Revenues & Volume, By Retail Pharmacy, 2020 - 2028 |
7 North America Hemophilia B Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Hemophilia B Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.2.1 United States (US) Hemophilia B Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.2.2 Canada Hemophilia B Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.2.3 Rest of North America Hemophilia B Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.3 North America Hemophilia B Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
7.3.1 United States (US) Hemophilia B Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.2 Canada Hemophilia B Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.3 Rest of North America Hemophilia B Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Hemophilia B Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.1 United States (US) Hemophilia B Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.2 Canada Hemophilia B Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.3 Rest of North America Hemophilia B Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Hemophilia B Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.1 United States (US) Hemophilia B Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.2 Canada Hemophilia B Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.3 Rest of North America Hemophilia B Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6 North America Hemophilia B Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.1 United States (US) Hemophilia B Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.2 Canada Hemophilia B Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.3 Rest of North America Hemophilia B Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Hemophilia B Market Key Performance Indicators |
9 North America Hemophilia B Market - Export/Import By Countries Assessment |
10 North America Hemophilia B Market - Opportunity Assessment |
10.1 North America Hemophilia B Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Hemophilia B Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10.3 North America Hemophilia B Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10.4 North America Hemophilia B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.5 North America Hemophilia B Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10.6 North America Hemophilia B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Hemophilia B Market - Competitive Landscape |
11.1 North America Hemophilia B Market Revenue Share, By Companies, 2022 |
11.2 North America Hemophilia B Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here